| Literature DB >> 35042832 |
Anette Arild1, Torgil Vangberg2,3, Hanne Nikkels4, Stian Lydersen5, Ulrik Wisløff6,7, Dorthe Stensvold6,7, Asta K Håberg1,4.
Abstract
We investigated if a five-year supervised exercise intervention with moderate-intensity continuous training (MICT) or high-intensity interval training (HIIT) versus control; physical activity according to national guidelines, attenuated the growth of white matter hyperintensities (WMH). We hypothesized that supervised exercise, in particular HIIT, reduced WMH growth. Older adults from the general population participating in the RCT Generation 100 Study were scanned at 3T MRI at baseline (age 70-77), and after 1-, 3- and 5-years. At each follow-up, cardiorespiratory fitness was measured with ergospirometry, and physical activity plus clinical data collected. Manually delineated total WMH, periventricular (PWMH), deep (DWMH), and automated total white matter hypointensity volumes were obtained. No group by time interactions were present in linear mixed model analyses with the different WMH measurements as outcomes. In the combined exercise (MICT&HIIT) group, a significant group by time interaction was uncovered for PWMH volume, with a larger increase in the MICT&HIIT group. Cardiorespiratory fitness at the follow-ups or change in cardiorespiratory fitness over time were not associated with any WMH measure. Contrary to our hypothesis, taking part in MICT or HIIT over a five-year period did not attenuate WMH growth compared to being in a control group following national physical activity guidelines.Entities:
Keywords: leukoaraiosis; physical fitness; prospective; randomized controlled trial; senior
Mesh:
Year: 2022 PMID: 35042832 PMCID: PMC8833118 DOI: 10.18632/aging.203843
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Figure 1Flowchart of participation, attrition and MRI data included in statistical analysis during the five-year intervention. Failed analysis included corrupted images, motion or other artifacts interfering with manual delineation and/or automated analysis (Figures 3 and 4).
Figure 3White matter hyperintensities (WMHs) depicted as white, well-defined lesions or confluent areas in white matter on fluid-attenuated inversion recovery (FLAIR) scans in three participants during the 5-year intervention period. The yellow arrows point to areas with growing WMH lesions (Subject 1) or a new lesion (Subject 2). The lower row shows the manually delineated WMHs (red outline) across 4 out of 176 slices in one participant.
Figure 4Flow chart of the multiparametric analysis of the brain MRI scans exemplified with scans from one participant. Upper row shows the 3D FLAIR, T1- and T2-weighted scans used. See Table 10 for scan details. Manual segmentation of white mater hyperintensities (WMH) was performed on the FLAIR images. From the T1-weighted scan, the ventricular (ventr.) mask derived with FreeSurfer (shown in violet in middle row) was used to stratify WMH into periventricular white mater hyperintensities (PWMH) (located <10 mm from the ventricular edge) and deep white mater hyperintensities (DWMH) (≥10 mm from ventricular edge) as seen in the lower row. PWMH are depicted in cyan and DWMH in white. White matter (WM)-hypointensity volume was also derived from the FreeSurfer analysis (middle row) and shown as green lesions. Intracranial volume (ICV) was calculated from the T1- and T2-weighted scans using SPM. These segmentations were performed separately for the scans from baseline, one-, three- and five years.
Demographic and clinical characteristics at baseline of participants in the RCT Generation 100 (G100) study taking and not taking part in the neuroimaging study.
|
|
|
| |
| Agea (years) | 72.6 (3.2) | 72.2 (2.6) |
|
| Womenb (%) | 50.5 | 49.5 | 0.845 |
| Educationa (%) |
| ||
| Primary school | 15.3 | 8.7 | |
| High school | 35.2 | 26.9 | |
| University | 49.5 | 64.4 | |
| Living aloneb (%) | 24.8 | 29.8 | 0.253 |
| Current smokerb (%) | 8.5 | 8.7 | 0.944 |
| Pack yearsa,c | 13.7 (18) | 11.3 (17) | 0.246 |
| Hypertensionb,d (%) | 55.9 | 49.0 | 0.179 |
| Diabetesb,e (%) | 8.6 | 4.7 | 0.160 |
| Waist circumferencef (cm) | 94.2 (11.1) | 93.7 (10.6) | 0.639 |
| Body mass indexf (kg/m2) | 26.0 (3.6) | 25.9 (3.3) | 0.848 |
| Triglyceridesa (mmol/L) | 1.0 (0.6) | 0.9 (0.5) |
|
| LDLa (mmol/L) | 3.4 (1.4) | 3.3 (1.5) | 0.621 |
| HDLa (mmol/L) | 1.7 (0.7) | 1.7 (0.7) |
|
| Total cholesterolf (mmol/L) | 5.6 (1.1) | 5.8 (1.0) | 0.246 |
| hsCRP (mg/L)a | 1.3 (1.8) | 1.2 (1.6) | 0.379 |
| VO2peakf (mL/kg/min) | 28.6 (6.4) | 30.3 (6.4) |
|
| Testing on bikeg (%) | 3.0 | 2.9 | 1.000 |
| Reached VO2maxb (%) | 59.9 | 65.4 | 0.269 |
| HADSf (total score) | 6.2 (4.4) | 4.6 (3.6) |
|
aMann-Whitney U-test (percentage or median and interquartile range (IQR)); bChi-square (percentage); cPack year: 20 cigarettes daily for one year; dHypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg and/or use of blood pressure medication; eDiabetes: fasting p-glucose ≥7.0 mmol/L and/or HbA1c ≥48 mmol/mol and/or diagnosed (type 1 or type 2). fIndependent t-test (mean and standard deviation (SD)); gFischer’s exact (percentage). Abbreviations: G100: Generation 100; LDL: low-density lipoprotein; HDL: high-density lipoprotein; hsCRP: high-sensitive C-reactive protein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycosylated hemoglobin; VO2peak: peak oxygen uptake, a combination of VO2max and VO2peak values; VO2max: maximal oxygen uptake; HADS: Hospital Anxiety and Depression Scale.
Comparison of the control, moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) exercise groups at baseline (A) and after five years (B).
|
| ||||
|
|
|
|
| |
| Agea (years) | 72.3 (2.4) | 71.8 (2.2) | 72.3 (3.1) | 0.791 |
| Womenb (%) | 52.1 | 54.2 | 42.4 | 0.607 |
| Educationb (%) | 0.501 | |||
| Primary school | 8.3 | 12.5 | 6.3 | |
| High school | 33.3 | 20.8 | 21.9 | |
| University | 58.3 | 66.7 | 71.9 | |
| Living situationb (%) | 0.953 | |||
| Alone | 31.3 | 29.2 | 28.1 | |
| With partner | 68.8 | 70.8 | 71.9 | |
| Current smokerc (%) | 10.4 | 4.3 | 9.4 | 0.817 |
| Pack yearsa,d | 9.8 (11) | 18.5 (40) | 13.8 (23) | 0.330 |
| Hypertensionb,e (%) | 50.0 | 47.8 | 45.2 | 0.915 |
| Diabetesc,f (%) | 2.1 | 8.7 | 6.5 | 0.432 |
| Waist circumferenceg (cm) | 93.3 (10.9) | 93.5 (9.2) | 94.4 (11.3) | 0.897 |
| Body mass indexg (kg/m2) | 25.9 (3.3) | 25.9 (3.4) | 26.1 (3.3) | 0.956 |
| Triglyceridesa (mmol/L) | 0.9 (0.4) | 0.9 (0.4) | 0.9 (0.5) | 0.958 |
| LDLa (mmol/L) | 3.5 (1.5) | 3.2 (1.1) | 3.3 (1.6) | 0.223 |
| HDLa (mmol/L) | 1.7 (0.7) | 1.7 (0.7) | 1.8 (0.8) | 0.917 |
| Total cholesterola (mmol/L) | 6.1 (1.7) | 5.6 (0.9) | 5.9 (1.4) | 0.145 |
| hsCRPa (mg/L) | 1.1 (1.4) | 1.0 (1.2) | 1.5 (1.6) | 0.431 |
| VO2peakg (mL/kg/min) | 30.3 (6.5) | 30.0 (5.7) | 30.4 (6.9) | 0.971 |
| Testing on a bikec (%) | 2.1 | 0.0 | 6.1 | 0.454 |
| Reached VO2maxb (%) | 64.6 | 52.2 | 75.8 | 0.187 |
| HADSa (total score) | 4 (5) | 4 (5) | 4 (5) | 0.953 |
|
| ||||
| Agea (years) | 76.8 (2.2) | 77.2 (1.9) | 77.4 (3.2) | 0.841 |
| Womenb (%) | 48.6 | 52.4 | 44.8 | 0.869 |
| Educationb (%) | 0.317 | |||
| Primary school | 2.9 | 14.3 | 7.1 | |
| High school | 31.4 | 14.3 | 17.9 | |
| University | 65.7 | 71.4 | 75.0 | |
| Living situationb (%) | 0.525 | |||
| Alone | 35.3 | 21.1 | 26.9 | |
| With partner | 64.7 | 78.9 | 73.1 | |
| Current smokerc (%) | 6.3 | 5.3 | 0.0 | 0.467 |
| Hypertensionb,e (%) | 64.5 | 44.4 | 52.0 | 0.362 |
| Diabetesc,f (%) | 0.0 | 11.8 | 8.7 | 0.110 |
| Waist circumferenceg (cm) | 94.2 (12.9) | 94.8 (8.9) | 94.7 (11.1) | 0.975 |
| Body mass indexg (kg/m2) | 25.9 (3.8) | 26.0 (3.6) | 26.0 (2.5) | 0.988 |
| Triglyceridesa (mmol/L) | 0.9 (0.5) | 0.8 (0.4) | 1.0 (0.6) | 0.261 |
| LDLg (mmol/L) | 3.4 (1.0) | 2.9 (1.0) | 3.1 (0.8) | 0.152 |
| HDLa (mmol/L) | 1.6 (0.7) | 1.6 (0.6) | 1.8 (0.6) | 0.724 |
| Total cholesterolg (mmol/L) | 5.6 (1.1) | 5.0 (1.1) | 5.5 (1.0) | 0.115 |
| hsCRPa (mg/L) | 1.4 (2.2) | 1.1 (1.3) | 1.5 (1.7) | 0.364 |
| VO2peakg (mL/kg/min) | 30.1 (7.6) | 28.6 (5.3) | 30.5 (6.1) | 0.633 |
| Testing on a bikec (%) | 2.7 | 10.5 | 8.0 | 0.506 |
| Reached VO2maxb (%) | 70.3 | 52.6 | 68.0 | 0.400 |
| HADSa (total score) | 5 (6) | 5 (5) | 3 (5) | 0.062 |
| MoCAa (total score) | 26 (4) | 27 (3) | 27 (3) | 0.270 |
aKruskal-Wallis H test (median and IQR); bChi-square (percentage); cFischer’s exact (percentage); dPack year: 20 cigarettes daily for one year; eHypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg and/or use of blood pressure medication; fDiabetes: fasting p-glucose ≥7.0 mmol/L and/or HbA1c ≥48 mmol/mol and/or diagnosed (type 1 or type 2). gOne-way ANOVA (mean and SD). Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-intensity interval training; LDL: low-density lipoprotein; HDL: high-density lipoprotein; hsCRP: high-sensitive C-reactive protein; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: glycosylated hemoglobin; VO2peak: peak oxygen uptake, a combination of VO2max and VO2peak values; VO2max: maximal oxygen uptake; HADS: Hospital Anxiety and Depression Scale; MoCA: Montreal Cognitive Assessment scores, presented as raw scores.
Figure 2Overview of the development of VO (A) Each line represents the VO2peak values for an individual participant according to group adherence with the thicker lines representing the mean of each group. (B) Box plot of VO2peak in the three intervention groups during the intervention period. (C) Each line represents the WMH volume as ‰ of ICV for an individual participant according to group adherence with the thicker lines representing the mean of each group. (D) Box plot of WMH volume as ‰ of ICV in the three intervention groups during the intervention. (E) Each line represents the WM-hypointensity volume as ‰ of ICV for an individual participant according to group adherence with the thicker lines representing the mean of each group. (F) Box plot of WM-hypointensity volume as ‰ of ICV in the three intervention groups during the intervention. In the box plots (B, D, and F), the box indicates the interquartile range with the top line of the box representing the third quartile and the bottom line representing the first quartile. The whiskers extend up to the minimum or maximum values, but no further than 1.5 times the interquartile range, and the black dots represent data beyond the end of the whiskers. Abbreviations: VO2peak: peak oxygen uptake; WMH: white matter hyperintensities; ICV: intracranial volume; WM: white matter; MICT: moderate-intensity continuous training; HIIT: high-intensity interval training.
Adherence to the allocated exercise program during the intervention period in the control, moderate-intensity continuous training (MICT), and high-intensity interval training (HIIT) groups.
|
|
|
|
|
|
| One-year follow-up | 38/42 (90.5%) | 16/21 (76.2%) | 23/31 (74.2%) | 0.136 |
| Three-year follow-up | 32/39 (82.1%) | 15/21 (71.4%) | 26/30 (86.7%) | 0.379 |
| Five-year follow-up | 33/35 (94.3%) | 18/21 (85.7%) | 23/29 (79.3%) | 0.184 |
Given as adhering/total number at each timepoint (percentage). aDifference between the groups at each timepoint was tested with Fischer’s exact test. Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-intensity interval training.
Weekly exercise frequency, duration, and intensity in the control, moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) group.
|
|
| |||||
|
|
|
|
|
|
| |
|
| ||||||
| Exercise frequency1 | 3.0 (1.3) | 2.8 (1.3) | 3.3 (1.3) | NS | NS | NS |
| Exercise duration2 | 45.7 (14.4) | 46.8 (8.2) | 47.9 (9.6) | NS | NS | NS |
| Minutes/week exercise | 140.2 (77.3) | 132.3 (75.5) | 157.5 (70.9) | NS | NS | NS |
| Exercise intensity3 | 13.8 (2.0) | 13.6 (0.9) | 15.2 (1.5) | 0.267 |
|
|
|
| ||||||
| Exercise frequency1 | 3.0 (1.7) | 2.9 (1.2) | 3.3 (1.4) | NS | NS | NS |
| Exercise duration2 | 46.1 (14.0) | 49.0 (10.0) | 47.5 (12.2) | NS | NS | NS |
| Minutes/week exercise | 146.9 (86.7) | 147.8 (53.8) | 155.5 (72.5) | NS | NS | NS |
| Exercise intensity3 | 13.2 (2.6) | 13.4 (0.9) | 15.6 (1.3) | 0.265 |
|
|
|
| ||||||
| Exercise frequency1 | 3.3 (1.6) | 2.8 (1.3) | 3.2 (1.4) | NS | NS | NS |
| Exercise duration2 | 48.4 (14.5) | 50.1 (10.0) | 44.4 (13.1) | NS | NS | NS |
| Minutes/week exercise | 168.3 (92.7) | 141.1 (75.3) | 138.5 (75.9) | NS | NS | NS |
| Exercise intensity3 | 13.4 (1.7) | 12.5 (2.1) | 15.0 (1.4) | 0.118 |
|
|
Difference between the groups at each timepoint was tested with Kruskal-Wallis test and if significant tested with Dunn’s test post-hoc. 1sessions per week; 2minutes per session; 3Borg scale, range 6–20. Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-intensity interval training; NS: not significant.
Frequency of different types of physical activity in the control, moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) group at each follow-up during the five-year intervention.
|
|
| |||||
|
|
|
|
|
|
| |
|
| ||||||
| Walkinga | 2.34 (1.20) | 2.47 (0.95) | 2.43 (1.72) | NS | NS | NS |
| Biking | 0.75 (0.93) | 1.03 (2.18) | 1.74 (2.09) | 0.198 |
|
|
| Swimming | 0.27 (0.49) | 0.21 (0.30) | 0.51 (0.76) | NS | NS | NS |
| Skiingb | 0.71 (1.08) | 0.71 (1.00) | 0.73 (0.92) | NS | NS | NS |
| Fitness center | 0.99 (1.19) | 0.96 (1.18) | 1.47 (1.36) | NS | NS | NS |
| Organized sports | 0.15 (0.39) | 0.27 (0.49) | 0.32 (0.59) | NS | NS | NS |
| Other activities | 0.23 (0.66) | 0.21 (0.39) | 0.53 (0.82) | NS | NS | NS |
|
| ||||||
| Walkinga | 2.26 (1.26) | 1.97 (1.36) | 2.54 (1.73) | NS | NS | NS |
| Biking | 0.77 (1.16) | 1.01 (2.01) | 1.54 (1.91) | NS | NS | NS |
| Swimming | 0.28 (0.60) | 0.09 (0.12) | 0.53 (0.66) | 0.097 |
|
|
| Skiingb | 0.68 (1.10) | 0.87 (1.70) | 0.72 (0.97) | NS | NS | NS |
| Fitness center | 0.87 (1.13) | 0.63 (0.83) | 1.34 (1.16) | NS | NS | NS |
| Organized sports | 0.30 (0.76) | 0.27 (0.39) | 0.59 (0.99) | NS | NS | NS |
| Other activities | 0.50 (0.68) | 0.56 (0.65) | 0.49 (0.63) | NS | NS | NS |
|
| ||||||
| Walkinga | 2.10 (1.21) | 1.81 (1.00) | 2.26 (1.63) | NS | NS | NS |
| Biking | 0.78 (1.38) | 0.39 (0.78) | 1.60 (2.16) | NS | NS | NS |
| Swimming | 0.33 (0.92) | 0.08 (0.12) | 0.43 (0.70) | NS | NS | NS |
| Skiingb | 0.56 (0.92) | 0.21 (0.33) | 0.49 (0.80) | NS | NS | NS |
| Fitness center | 0.91 (1.30) | 0.32 (0.64) | 1.19 (1.13) | 0.051 |
| 0.077 |
| Organized sports | 0.38 (1.10) | 0.42 (0.80) | 0.51 (0.83) | NS | NS | NS |
| Other activities | 0.37 (0.52) | 0.61 (0.62) | 0.44 (0.40) | NS | NS | NS |
Data are presented as self-reported weekly frequency of listed activities. Difference between the groups at each timepoint was tested with Kruskal-Wallis test and if significant tested with Dunn’s test post-hoc. aWalking: as transport, recreational walking, or hiking, bcross-country skiing. Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-intensity interval training; NS: not significant.
Total (A) and relative to ICV (B) WMH, PWMH, DWMH and WM-hypointensity volumes at each timepoint for all participants, given as median and interquartile range.
|
|
|
|
|
|
|
| ||||
| Baseline | 4.1 (8.4) | 3.3 (6.5) | 0.6 (2.3) | 3.5 (3.2) |
| One-year follow-up | 5.7 (12.1) | 4.7 (8.0) | 0.9 (2.7) | 4.0 (3.3) |
| Three-year follow-up | 8.8 (14.6) | 7.1 (11.3) | 1.3 (2.8) | 5.0 (5.5) |
| Five-year follow-up | 19.2 (14.2) | 15.7 (12.7) | 3.0 (3.6) | 6.1 (6.0) |
|
| ||||
| Baseline | 2.5 (5.4) | 2.2 (3.9) | 0.4 (1.4) | 2.2 (2.0) |
| One-year follow-up | 3.5 (7.6) | 3.1 (5.1) | 0.6 (1.6) | 2.5 (2.2) |
| Three-year follow-up | 5.6 (8.7) | 4.4 (5.9) | 0.7 (1.6) | 3.0 (3.3) |
| Five-year follow-up | 11.9 (7.8) | 10.3 (7.1) | 1.8 (2.0) | 3.5 (3.4) |
In (B) the WMH, PWMH, DWMH and WM-hypointensity volumes were divided by ICV and multiplied by 1000, i.e., reported as ‰ of ICV. Abbreviations: WMH: white matter hyperintensities; PWMH: periventricular WMH; DWMH: deep WMH; WM: white matter; IQR: interquartile range.
The effect of the five-year intervention on WMH, PWMH, DWMH and WM-hypointensity volumes in the MICT and HIIT groups compared to the control group.
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Women | 1.95 | −1.29, 5.19 | 0.235 | 0.83 | −1.13, 2.79 | 0.404 | 1.14 | −0.35, 2.62 | 0.131 | −0.80 | −1.83, 0.22 | 0.124 |
| Age | 0.28 | −0.56, 1.12 | 0.507 | 0.48 | −0.03, 0.98 | 0.067 | −0.14 | −0.51, 0.23 | 0.447 | 0.33 | 0.06, 0.60 |
|
| 1-Year | 1.03 | −0.71, 2.77 | 0.245 | 0.47 | −0.69, 1.64 | 0.424 | 0.81 | 0.16, 1.46 |
| −0.03 | −0.62, 0.56 | 0.921 |
| 3-Year | 2.35 | −0.58, 5.27 | 0.115 | 1.17 | −0.67, 3.01 | 0.212 | 1.22 | 0.01, 2.44 |
| 0.09 | −0.87, 1.04 | 0.856 |
| 5-Year | 7.58 | 3.00, 12.16 |
| 4.50 | 1.67, 7.33 |
| 2.62 | 0.65, 4.59 |
| 0.53 | −0.94, 2.00 | 0.477 |
| MICT | −0.89 | −5.19, 3.42 | 0.683 | −0.59 | −3.24, 2.05 | 0.659 | −0.24 | −2.16, 1.69 | 0.808 | −0.23 | −1.61, 1.15 | 0.739 |
| HIIT | −2.11 | −6.02, 1.81 | 0.288 | −1.54 | −3.94, 0.86 | 0.205 | −0.30 | −2.05, 1.45 | 0.733 | −0.72 | −1.97, 0.53 | 0.258 |
| MICT*1-year | −0.41 | −2.66, 1.83 | 0.718 | −0.18 | −1.76, 1.41 | 0.828 | −0.31 | −0.98, 0.36 | 0.368 | −0.31 | −1.12, 0.51 | 0.457 |
| MICT*3-year | 0.77 | −1.55, 3.09 | 0.515 | 0.61 | −1.03, 2.24 | 0.466 | 0.05 | −0.65, 0.74 | 0.899 | 0.12 | −0.71, 0.95 | 0.770 |
| MICT*5-year | 0.97 | −1.34, 3.28 | 0.408 | 1.20 | −0.43, 2.83 | 0.147 | 0.10 | −0.60, 0.79 | 0.783 | −0.57 | −1.39, 0.25 | 0.174 |
| HIIT*1-year | 0.42 | −1.58, 2.43 | 0.679 | 0.20 | −1.21, 1.61 | 0.277 | −0.21 | −0.81, 0.39 | 0.498 | −0.03 | −0.74, 0.69 | 0.942 |
| HIIT*3-year | 0.71 | −1.33, 2.76 | 0.493 | 0.52 | −0.92, 1.95 | 0.480 | −0.11 | −0.73, 0.50 | 0.719 | −0.16 | −0.89, 0.56 | 0.658 |
| HIIT*5-year | 1.38 | −0.71, 3.47 | 0.193 | 1.46 | −0.00, 2.92 | 0.050 | −0.25 | −0.88, 0.38 | 0.439 | −0.37 | −1.10, 0.37 | 0.326 |
| AIC | 2095.1 | 1812.4 | 1330.1 | 1379.2 | ||||||||
WMH, PWMH, DWMH, WM-Hypointensity volumes were corrected for ICV and multiplied by 1000 (‰ of ICV). All analyses were adjusted for age, sex, and baseline outcome values. The control group was the reference group. There were no interactions between sex, age, time (year one, three and five) or the training interventions (MICT and HIIT) and these terms were therefore removed from the statistical models. Abbreviations: WMH: white matter hyperintensities; PWMH: periventricular WMH; DWMH: deep WMH; WM: white matter; Est.: estimates; CI: confidence interval; MICT: moderate-intensity continuous training; HIIT: high-intensity interval training; AIC: Akaike’s information criterion.
A longitudinal linear mixed model of WMH, PWMH, DWMH and WM-hypointensity volumes with VO2peak at time of each follow up as a predictor across all participants.
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Women | 2.21 | −1.04, 5.45 | 0.181 | 0.98 | −0.99, 2.96 | 0.327 | 1.23 | −0.32, 2.78 | 0.118 | −0.93 | −1.96, 0.10 | 0.076 |
| Age | 0.27 | −0.56, 1.10 | 0.518 | 0.47 | −0.04, 0.97 | 0.071 | −0.18 | −0.57, 0.21 | 0.369 | 0.30 | 0.04, 0.57 |
|
| Year one | 1.03 | −0.47, 2.52 | 0.176 | 0.49 | −0.47, 1.45 | 0.313 | 0.77 | 0.10, 1.44 |
| −0.03 | −0.53, 0.47 | 0.919 |
| Year three | 2.72 | −0.04, 5.48 | 0.053 | 1.49 | −0.23, 3.20 | 0.088 | 1.37 | 0.08, 2.65 |
| 0.23 | −0.67, 1.12 | 0.617 |
| Year five | 8.39 | 3.96, 12.81 |
| 5.40 | 2.68, 8.11 |
| 3.05 | 0.97, 5.13 |
| 0.47 | −0.94, 1.89 | 0.509 |
| VO2peak | −0.00 | −0.12, 0.12 | 0.998 | −0.01 | −0.09, 0.07 | 0.778 | −0.00 | −0.05, 0.05 | 0.900 | −0.03 | −0.07, 0.01 | 0.153 |
| AIC | 1986.4 | 1713.3 | 1422.7 | 1314.5 | ||||||||
WMH, PWMH, DWMH, WM-hypointensity volumes were corrected for ICV and multiplied by 1000 (‰ of ICV). All analyses were adjusted for age, sex, and baseline outcome values. The control group was the reference group. There were no interactions between sex, age, time (year one, three and five) or VO2peak and these terms were therefore removed from the statistical models. Abbreviations: WMH: white matter hyperintensities; PWMH: periventricular WMH; DWMH: deep WMH; WM: white matter; Est.: estimates; CI: confidence interval; VO2peak: peak oxygen uptake; AIC: Akaike’s information criterion.
Linear mixed ‘model of changes’ analyses with yearly change in VO2peak (ΔVO2peak) as predictor of yearly change in WMH, PWMH, DWMH, and WM-hypointensity volumes across all participants.
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Women | 0.28 | −0.34, 0.90 | 0.380 | 0.17 | −0.23, 0.58 | 0.400 | 0.26 | 0.03, 0.50 |
| −0.09 | −0.29, 0.11 | 0.363 |
| Agea | 0.18 | 0.04, 0.32 |
| 0.16 | 0.07, 0.26 |
| −0.02 | −0.07, 0.03 | 0.396 | 0.03 | −0.01, 0.08 | 0.136 |
| ΔVO2peak | 0.09 | −0.01, 0.19 | 0.088 | 0.04 | −0.03, 0.11 | 0.266 | 0.02 | −0.02, 0.05 | 0.291 | 0.01 | −0.02, 0.04 | 0.484 |
| AIC | 985.2 | 800.4 | 531.0 | 476.6 | ||||||||
WMH, PWMH, DWMH, WM-hypointensity volumes were corrected for ICV and multiplied by 1000 (‰ of ICV). Yearly changes were calculated from inclusion to one-year, one-year to three-year, and three-year to five-year of the intervention. There were no interactions between sex, age, or VO2peak and these terms were therefore removed from the statistical models. aThe participants’ mean age at each time interval. 2Yearly change in peak oxygen uptake of the three follow up intervals. Abbreviations: WMH: white matter hyperintensities; PWMH: periventricular WMH; DWMH: deep WMH; WM: white matter; Est.: estimates; CI: confidence interval; VO2peak: peak oxygen uptake.
MRI scan parameters for scans acquired at 3T used in this study.
|
|
|
|
|
|
| Sagittal | Sagittal | Sagittal |
|
| 1900 ms | 3200 ms | 5000 ms |
|
| 3.16 ms | 412 ms | 388 ms |
|
| 900 ms | n/a | 1650 ms |
|
| 192 | 176 | 176 |
|
| 1.0 mm | 1.0 mm | 1.0 mm |
|
| 256 × 256 mm | 250 × 250 mm | 256 × 256 mm |
|
| 256 × 256 | 256 × 256 | 256 × 256 |
|
| 9° | T2 variable | T2 variable |
|
| 224 | 282 | 278 |
|
| 1 | 1 | 1 |
Abbreviations: FLAIR: fluid-attenuated inversion recovery; TR: repetition time; TE: echo time; TI: inversion time; FOV: field-of-view; ETL: echo train length.